The global prenatal diagnostic market is anticipated to grow at a considerable CAGR of 12.9% during the forecast period. One of the factors that are fueling the market is the contribution of the university in research and development for the prenatal diagnostic and product portfolio expansion strategy adopted by market players are further fuiling the market growth. For instance,
OPKO health’s buyout US Arisona- in August 2021, OPKO health’s inc. recently announced the buyout of the US arisona centralized laboratory prenatal testing business from Roche Holding AG. The buyout will help in the expansion of bio references noninvasive prenatal screening, which is unable to accelerate high-quality testing that can have favorable impacts on the medical care and outcomes of patients.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/prenatal-diagnostic-market
UC Davis adds two new prenatal diagnostic centers – in February 2020, UC Davis Health has added two new prenatal diagnostic centers (PDC) clinics in Sacremento and Stokton. The purpose of the expansion was to provide pregnant women a comprehensive counseling, genetic screening, and diagnostic testing for monitoring fetal anomalies such as chorionic villus sampling(CVS) and amniocentesis.
Research support expansion of insurance plan of non-invasive prenatal testing – the research conducted by the University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, presents first of its kind published an analysis of results from an agreement between Illumina inc., and insurer Harvard Pilgrim Health Care to expand insurance coverage of noninvasive prenatal test for pregnant women.
Market Coverage
- The market number available for – 2020-2027
- Base year- 2020
- Forecast period- 2021-2027
- Segment Covered-
o By Method
o By Test type
o By End-User
- Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
- Competitive Landscape- Abbott,Eurofines Scientific, Illumina’s , Myriad Genetics Inc., Quest Diangostics Inco., Hologic Inc., Natera Inc. and others.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Prental Diagnostic Market Report by Segment
By Method
- Blood
- Urine
- Ultrasound
- Amniocentesis
- Others (percutaneous umbilical blood sampling)
By Test Type
- Invasive
- Non-Invasive
By End-User
- Hospitals
- Speciality Clincs
- Diagnostic Centers
A full report of Prenatal Diagnostic Market is available at: https://www.omrglobal.com/industry-reports/prenatal-diagnostic-market
Prenatal Diagnostic Market– Segment by Region
North America
- United States
- Canada
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
- Middle East & Africa
- Latin America
Company Profiles
- Abbott Molecular
- America Holdings
- Angle Plc.
- Ariosa Diagnostics
- Eurofins NTD Inc.
- GeneDx
- Hologic Inc.,
- Illumina, Inc
- Laboratory Corp
- Myriad Genetics Inc.,
- Natera, Inc.
- PerkinElmer, Inc.
- Prenatal Paternities Inc
